Refine by
Genomic Test Equipment & Supplies In Palau
9 equipment items found
Manufactured by:Guardant Health, Inc. based inRedwood City, CALIFORNIA (USA)
Our Guardant360® CDx test is FDA-approved for complete genomic testing across all solid cancers, providing doctors guideline-complete genomic results in 7 days from a simple blood draw to inform treatment decisions. A blood test does not require tissue testing, enabling more patients to ...
by:Exact Sciences UK, Ltd. based inLondon, UNITED KINGDOM
Every cancer is unique and affects each diagnosed person differently based on the individual biology of his or her disease. To address this diversity and make cancer care smarter at every stage, our Oncotype DX genomic tests and services portfolio delivers clinically relevant genomic intelligence that reveals the individual biology of a patient's ...
Manufactured by:XPhyto Therapeutics Corporation based inVancouver, BRITISH COLUMBIA (CANADA)
XPhyto Therapeutics is focused on helping economies restart and businesses get up and running to bring life back to normal with a rapid, accurate and cost effective COVID ...
Manufactured by:Amoy Diagnostics Co., Ltd. based inXiamen, CHINA
Lung cancer is one of the most common malignant tumor, and 80~85% of lung cancers are non-small cell lung cancer (NSCLC). There are many driver mutations in NSCLC. The frequency of mutations in NSCLC for EGFR, HER2, KRAS and BRAF genes are respectively 10-50%, 1-4%, 5-25% and 1-2%. About 3-7%, 1%, 1%, 0.12%, 0.02%, 0.08% of NSCLC patients have gene fusions in ALK, ROS1, RET, NTRK1, NTRK2 and ...
Manufactured by:NeraCare GmbH based inFrankfurt, GERMANY
Melanoma is a serious form of skin cancer that begins in cells known as melanocytes. While it is less common than basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), melanoma is far more dangerous because of its ability to spread to other organs more rapidly if it not treated at an early ...
by:Natera, Inc. based inAustin, TEXAS (USA)
Support treatment decisions with comprehensive tumor profiling. Gain deep insight into the tumor’s genomic alterations and oncology biomarkers with Altera. The detailed sequencing report includes FDA-approved treatments, novel treatment approaches and ongoing clinical trials targeting found mutations. Unlike any other tumor profiling assay, Altera also enables molecular residual disease ...
Manufactured by:Pacific Edge Ltd based inDunedin,, NEW ZEALAND
Cxbladder is a non-invasive genomic urine test that quickly and accurately detects or rules out bladder cancer. The tests works at a molecular level, measuring five biomarker genes to detect the presence or absence of bladder cancer1, and comes as a suite of three product variations, each optimised for a different point in the patient ...
Manufactured by:Co-Diagnostics, Inc. based inSalt Lake City, UTAH (USA)
The Logix Smart™ ZDC (ZIKV-DENV-CHIKV) Test kit uses our patented CoPrimer™ technology to differentiate between the ribonucleic acid (RNA) of Zika, dengue (all 4 serotypes), and chikungunya viruses and to detect and amplify regions of the viruses’ genomes. The test operates using a single step real-time reverse transcriptase ...
Manufactured by:OncoDNA S.A. based inGosselies, BELGIUM
Oncodeep® is a comprehensive biomarker test designed to guide treatment of advanced, metastatic solid tumors. When your patients are diagnosed with a rare cancer type or an aggressive cancer, when chemotherapy doesn't work or when cancer comes back, OncoDEEP® can provide you with clear clinical guidance. Starting from a small sample of tumor tissue, our biomarker test is able to pinpoint ...